Meloxicam Recruiting Phase 3 Trials for Migraine Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04163185Initiating Early Control of Migraine Pain and Associated Symptoms